HK1044117B - 藥物組合物 - Google Patents

藥物組合物 Download PDF

Info

Publication number
HK1044117B
HK1044117B HK02105428.9A HK02105428A HK1044117B HK 1044117 B HK1044117 B HK 1044117B HK 02105428 A HK02105428 A HK 02105428A HK 1044117 B HK1044117 B HK 1044117B
Authority
HK
Hong Kong
Prior art keywords
vitamin
oil
pharmaceutical composition
composition
compound
Prior art date
Application number
HK02105428.9A
Other languages
English (en)
Chinese (zh)
Other versions
HK1044117A1 (en
Inventor
戴维‧莫里斯
戴維‧莫里斯
Original Assignee
Mrc控股有限公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mrc控股有限公司 filed Critical Mrc控股有限公司
Publication of HK1044117A1 publication Critical patent/HK1044117A1/xx
Publication of HK1044117B publication Critical patent/HK1044117B/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/138—Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
HK02105428.9A 1998-05-04 1999-05-04 藥物組合物 HK1044117B (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
AUPP3328A AUPP332898A0 (en) 1998-05-04 1998-05-04 Pharmaceutical composition
AUPP3328 1998-05-04
PCT/AU1999/000323 WO1999056697A2 (en) 1998-05-04 1999-05-04 Pharmaceutical composition

Publications (2)

Publication Number Publication Date
HK1044117A1 HK1044117A1 (en) 2002-10-11
HK1044117B true HK1044117B (zh) 2005-10-21

Family

ID=3807582

Family Applications (1)

Application Number Title Priority Date Filing Date
HK02105428.9A HK1044117B (zh) 1998-05-04 1999-05-04 藥物組合物

Country Status (9)

Country Link
US (1) US6664246B2 (enExample)
EP (1) EP1124557A4 (enExample)
JP (1) JP2002513733A (enExample)
KR (1) KR20010052305A (enExample)
CN (1) CN1204893C (enExample)
AU (1) AUPP332898A0 (enExample)
HK (1) HK1044117B (enExample)
WO (1) WO1999056697A2 (enExample)
ZA (1) ZA200006953B (enExample)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6087350A (en) 1997-08-29 2000-07-11 University Of Pittsburgh Of The Commonwealth System Of Higher Education Use of pretreatment chemicals to enhance efficacy of cytotoxic agents
US7129230B2 (en) * 2001-03-12 2006-10-31 Nestec S.A. Method and product for treating cancer in pets
US20050038022A1 (en) * 2001-03-26 2005-02-17 Unisearch Limited Method for treatment of cancer and compositions for use therein
AUPR644301A0 (en) * 2001-07-17 2001-08-09 Unisearch Limited Method and composition for treatment of cancer
US20050209551A1 (en) * 2004-03-18 2005-09-22 Takemoto Arnold C Detoxification and breast health preparations
CA2558202A1 (en) * 2006-09-14 2006-11-23 Reinhold W. Vieth Vitamin d compositions and method of administration to infants
ITMI20121041A1 (it) 2012-06-15 2013-12-16 Lga Biotecnologie S R L Chemioprevenzione del cancro del colon - retto
CN106109476A (zh) * 2016-06-13 2016-11-16 中山大学 骨化二醇作为吲哚胺2,3‑双加氧酶‑1抑制剂的用途

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5260067A (en) * 1988-11-16 1993-11-09 Xu Zheng Cytotropic heterogeneous molecular lipids (CHML) and process for preparing the same
US5798345A (en) * 1990-09-21 1998-08-25 Bone Care International, Inc. Method of inhibiting the hyperproliferation of malignant cells
US5486509A (en) * 1991-06-28 1996-01-23 University Of Miami Method of preventing and treating chemotherapy-induced alopecia
EP0619305B1 (en) * 1993-02-05 1997-06-04 Teijin Limited Lactone compound and process of producing thereof
AUPO727097A0 (en) * 1997-06-10 1997-07-03 Unisearch Limited Method of treatment of hepatoma and pharmaceutical compositions for use therein
CN1090180C (zh) * 1997-06-25 2002-09-04 帝人株式会社 维生素d3衍生物及其用于炎性呼吸道疾病的治疗剂

Also Published As

Publication number Publication date
WO1999056697A2 (en) 1999-11-11
WO1999056697A3 (en) 2001-06-21
EP1124557A4 (en) 2002-08-07
CN1204893C (zh) 2005-06-08
EP1124557A2 (en) 2001-08-22
US20020128239A1 (en) 2002-09-12
KR20010052305A (ko) 2001-06-25
HK1044117A1 (en) 2002-10-11
CN1332629A (zh) 2002-01-23
JP2002513733A (ja) 2002-05-14
US6664246B2 (en) 2003-12-16
ZA200006953B (en) 2002-03-28
AUPP332898A0 (en) 1998-05-28

Similar Documents

Publication Publication Date Title
KR100382219B1 (ko) 간 종양 치료용 조성물
US6448287B1 (en) Treatment of cancer using lipoic acid in combination with ascorbic acid
JP2681147B2 (ja) がん性腫瘍転移の治療剤
US20140294964A1 (en) Compositions and methods for treating cancer with dacarbazine nanoemulsions
Ricciardolo et al. Impairment of bronchoprotection by nitric oxide in severe asthma
CN1204893C (zh) 药物组合物
US20140162991A1 (en) Testosterone-anastrozole (t + a) combination implants in the neo-adjuvant, local and systemic therapy of newly diagnosed, previously untreated breast cancer
JP2002302447A (ja) 局所投与用癌治療剤
CN1551771A (zh) 用于治疗癌症的方法和组合物
AU765846B2 (en) Pharmaceutical composition
Matsumura et al. Intravesical adriamycin chemotherapy in bladder cancer
Keller et al. Growth inhibition of experimental non‐Hodgkin's lymphomas with the targeted cytotoxic somatostatin analogue AN‐238
CN114423458A (zh) 含有对二羟硼基苯丙氨酸的注射液剂
EP1477174A1 (en) Radioactive arsenic-containing compounds and their uses in the treatment of tumors
Nickerson et al. First-pass metabolism and biliary recirculation of droloxifene in the female Sprague-Dawley rat
Kullander LHRH agonist treatment in ovarian cancer
CN1065769C (zh) 一种放射性药物制剂的制备方法
CN118750445A (zh) 一种肝脏特异性靶向纳米制剂和应用
Fu et al. Response of intramuscular walker 256 rat tumor to sustained‐release cyclophosphamide and ara‐c capsules
HK1030144B (en) Method for treatment of liver tumours and pharmaceutical compositions for use therein
Vijayan et al. Substance P and neurotensin: Opposite effects on plasma cholesterol levels in ovariectomized conscious rats
Kaisary et al. MP-18.07: Phase III Efficacy and Safety Trial of a New Leuprolide Acetate 3.75 Mg Depot Formulation in Prostate Cancer Patients
Savina The effects of perfusion rates and bile salts on the absorption clearance of iopanoic acid.
HK1070280A (en) Method and composition for treatment of cancer
AU2002318983A1 (en) Mathod and composition for treatment of cancer

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20090504